Drug Topics

Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…

In a recent Drug Topics live interview at NCPDP 2025, Prescryptive’s SVP of Provider Solutions, Miranda Rochol, shares…

Miranda Rochol, Senior Vice President at Prescryptive Health, is leading the charge in transforming how healthcare consumers interact…

Already, one in four neighborhoods can be considered a pharmacy desert, and with one-third of independent pharmacies expected…

Drug Topics shares our news that NCPA “has renewed its recommendation of Prescryptive Health’s artificial intelligence pricing system,…

Douglas Hoey, CEO of NCPA, shared his thoughts on the current pharmacy payment model with Drug Topics and…

Drug Topics examines how technology can help pharmacists offer high-quality customer service. Prescryptive’s own Paige Clark, RPh, weighs…

Take a look back at the most popular Total Pharmacy coverage for 2022, including the NCPA recommendation of…

See highlights for the annual NCPA convention in Kansas City, including sessions from Prescryptive Health! Conference Preview: NCPA Annual…

Paige Clark, RPh and VP of Pharmacy Programs and Policy talks to Drug Topics about this issue and…

For pharmacists, POC testing is important far beyond COVID-19. @PrescryptiveH’s Paige Clark discusses how community pharmacists can and…